<p>Indivior PLC (LON:INDV - 获取免费报告) 在周一交易中下跌了 5%。该公司的股价最低跌至 768 便士（9.96 美元），最后报 774 便士（10.04 美元）。在午盘交易中，有 1,059,445 股交易，比平均交易量 544,839 股增加了 94%。该股票此前收盘价为 814.50 便士（10.56 美元）。</p>
<h2>分析师评级变动</h2>
<p>德意志银行降低了对 Indivior 的目标股价，从 2,350 便士（30.48 美元）降至 1,500 便士（19.45 美元），并在 7 月 9 日星期二的研究报告中为该公司设定了 “买入” 评级。</p>
<p><strong>获取我们对 Indivior 的最新分析</strong></p>
<h2>Indivior 交易下跌 5.0%</h2>
<p>该公司的 50 天简单移动平均线为 1,273.11 便士，200 天简单移动平均线为 1,409.72 便士。公司的资产负债比为 2,790.00，速动比率为 1.52，流动比率为 0.93。该公司的市值为 10.5 亿英镑，市盈率为 25,800.00，市盈增长比率为-5.57，贝塔系数为 0.06。</p>
<h2>关于 Indivior（获取免费报告）</h2>
<p>Indivior PLC 及其子公司从事在美国、英国和国际市场开发、生产和销售基于丁丙诺啡的处方药，用于治疗阿片类依赖和并发症。该公司开发药物用于治疗物质使用障碍、严重精神疾病和阿片类药物过量。</p>
<h2>精选故事</h2>
<ul>
<li>五支我们比 Indivior 更看好的股票</li>
<li>什么是纳斯达克证券交易所？</li>
<li>汽车制造商向电动汽车未来的大胆举措：是时候买入股票了吗？</li>
<li>3 支引领迷因股复苏的股票</li>
<li>大突破：这只 ETF 预示着小盘股大涨</li>
<li>如何计算期权利润</li>
<li>值得关注的主要游戏股：为什么现在是一个安全的押注时机</li>
</ul>
<p><em>这则即时新闻警报是由叙事科技和 MarketBeat 的财务数据生成的，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队的审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 发布后，攻击将会找上我...（来自 Porter &amp; Company）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NzUx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NzUx"/></p>
<h2>您现在是否应该投资 1,000 美元购买 Indivior 股票？</h2>
<p>在考虑购买 Indivior 股票之前，您需要听到这个消息。</p>
<p>MarketBeat 追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户现在购买的股票清单... Indivior 不在其中。</p>
<p>尽管 Indivior 目前在分析师中具有 “买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
<p>查看这五支股票</p>

INDV

<p>Indivior (LON:INDV) 股价周一交易中下跌了 5%，交易量有所增加。德意志银行下调了对 Indivior 的目标价。该公司开发并销售用于阿片类药物依赖治疗的处方药</p>

<p>Indivior PLC (LON:INDV - Get Free Report) fell 5% during trading on Monday . The company traded as low as GBX 768 ($9.96) and last traded at GBX 774 ($10.04). 1,059,445 shares changed hands during mid-day trading, an increase of 94% from the average session volume of 544,839 shares. The stock had previously closed at GBX 814.50 ($10.56).</p>
<div class="lb-trans"><p>Indivior PLC (LON:INDV - 获取免费报告) 在周一交易中下跌了 5%。该公司的股价最低跌至 768 便士（9.96 美元），最后报 774 便士（10.04 美元）。在午盘交易中，有 1,059,445 股交易，比平均交易量 544,839 股增加了 94%。该股票此前收盘价为 814.50 便士（10.56 美元）。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Separately, Deutsche Bank Aktiengesellschaft lowered their price target on Indivior from GBX 2,350 ($30.48) to GBX 1,500 ($19.45) and set a &#34;buy&#34; rating for the company in a research report on Tuesday, July 9th.</p>
<div class="lb-trans"><p>德意志银行降低了对 Indivior 的目标股价，从 2,350 便士（30.48 美元）降至 1,500 便士（19.45 美元），并在 7 月 9 日星期二的研究报告中为该公司设定了 “买入” 评级。</p>
</div><p><strong>Get Our Latest Analysis on Indivior</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Indivior 的最新分析</strong></p>
</div><h2>Indivior Trading Down 5.0 %</h2>
<div class="lb-trans"><h2>Indivior 交易下跌 5.0%</h2>
</div><p>The firm has a 50 day simple moving average of GBX 1,273.11 and a 200 day simple moving average of GBX 1,409.72. The company has a debt-to-equity ratio of 2,790.00, a quick ratio of 1.52 and a current ratio of 0.93. The firm has a market cap of £1.05 billion, a P/E ratio of 25,800.00, a P/E/G ratio of -5.57 and a beta of 0.06.</p>
<div class="lb-trans"><p>该公司的 50 天简单移动平均线为 1,273.11 便士，200 天简单移动平均线为 1,409.72 便士。公司的资产负债比为 2,790.00，速动比率为 1.52，流动比率为 0.93。该公司的市值为 10.5 亿英镑，市盈率为 25,800.00，市盈增长比率为-5.57，贝塔系数为 0.06。</p>
</div><h2>About Indivior (Get Free Report)</h2>
<div class="lb-trans"><h2>关于 Indivior（获取免费报告）</h2>
</div><p>Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.</p>
<div class="lb-trans"><p>Indivior PLC 及其子公司从事在美国、英国和国际市场开发、生产和销售基于丁丙诺啡的处方药，用于治疗阿片类依赖和并发症。该公司开发药物用于治疗物质使用障碍、严重精神疾病和阿片类药物过量。</p>
</div><h2>Featured Stories</h2>
<ul>
<li>Five stocks we like better than Indivior</li>
<li>What is the NASDAQ Stock Exchange?</li>
<li>Automaker's Bold Move to an EV Future: Is It Time to Buy Stock?</li>
<li>3 Tickers Leading a Meme Stock Revival</li>
<li>Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks</li>
<li>How to Calculate Options Profits</li>
<li>Major Gaming Stock to Watch: Why It's a Safe Bet Now</li>
</ul>
<div class="lb-trans"><h2>精选故事</h2>
<ul>
<li>五支我们比 Indivior 更看好的股票</li>
<li>什么是纳斯达克证券交易所？</li>
<li>汽车制造商向电动汽车未来的大胆举措：是时候买入股票了吗？</li>
<li>3 支引领迷因股复苏的股票</li>
<li>大突破：这只 ETF 预示着小盘股大涨</li>
<li>如何计算期权利润</li>
<li>值得关注的主要游戏股：为什么现在是一个安全的押注时机</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由叙事科技和 MarketBeat 的财务数据生成的，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队的审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ The attacks will come for me after releasing this… (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ 发布后，攻击将会找上我...（来自 Porter &amp; Company）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NzUx" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8751&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Indivior right now?</h2>
<div class="lb-trans"><h2>您现在是否应该投资 1,000 美元购买 Indivior 股票？</h2>
</div><p>Before you consider Indivior, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑购买 Indivior 股票之前，您需要听到这个消息。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户现在购买的股票清单... Indivior 不在其中。</p>
</div><p>While Indivior currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Indivior 目前在分析师中具有 “买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五支股票</p>
</div>

Indivior (LON:INDV) 股价下跌 5%